196170 — Alteogen Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapFalling Star

Annual cashflow statement for Alteogen, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-9,191	-10,078	-3,582	60,690	145,173
Depreciation
Amortisation
Non-Cash Items	-65.5	-12,023	-1,091	-28,609	-20,193
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-2,314	1,572	-6,426	18,113	-6,342
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-9,420	-17,875	-7,766	53,044	124,127
Capital Expenditures	-24,076	-42,492	-43,442	-24,447	-33,417
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-101,885	92,705	34,099	-83,325	-197,703
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-125,961	50,213	-9,343	-107,771	-231,120
Financing Cash Flow Items	-36.5	-22.4	0	—	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	107,003	2,919	1,737	43,259	155,645
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-28,383	35,289	-15,629	-11,206	47,387